Your session is about to expire
← Back to Search
Hormone Therapy
Oxytocin for Postpartum Depression (IN-OXT Trial)
Phase 2
Waitlist Available
Led By Sharon Dekel, PhD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
At risk of postpartum depression (PPD)
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 months postpartum
Awards & highlights
IN-OXT Trial Summary
This trial is testing whether oxytocin can prevent mental illness in mothers after childbirth.
Eligible Conditions
- Postpartum Depression
- Anxiety
IN-OXT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
You are at risk of experiencing depression after giving birth.
IN-OXT Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 months postpartum
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 months postpartum
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Treatment effect on mother-infant bonding
Secondary outcome measures
Change in anxiety symptoms
Change in depression symptoms
Child development
IN-OXT Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: OxytocinActive Control1 Intervention
Sub-group of participants receiving oxytocin nasal spray (Syntocinon)
Group II: PlaceboPlacebo Group1 Intervention
Sub-group of participants receiving placebo nasal spray
Find a Location
Who is running the clinical trial?
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,953 Previous Clinical Trials
2,660,424 Total Patients Enrolled
6 Trials studying Postpartum Depression
4,286 Patients Enrolled for Postpartum Depression
Massachusetts General HospitalLead Sponsor
2,923 Previous Clinical Trials
13,193,337 Total Patients Enrolled
2 Trials studying Postpartum Depression
22 Patients Enrolled for Postpartum Depression
Sharon Dekel, PhDPrincipal InvestigatorMassachusetts General Hosptial
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger